Citigroup’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$255K Buy
52,374
+34,291
+190% +$167K ﹤0.01% 3238
2025
Q1
$66.9K Buy
18,083
+428
+2% +$1.58K ﹤0.01% 4022
2024
Q4
$70.6K Buy
17,655
+1,045
+6% +$4.18K ﹤0.01% 4129
2024
Q3
$116K Buy
16,610
+11,569
+229% +$80.6K ﹤0.01% 3932
2024
Q2
$28.6K Sell
5,041
-42,671
-89% -$242K ﹤0.01% 4149
2024
Q1
$636K Buy
+47,712
New +$636K ﹤0.01% 2702
2022
Q4
Sell
-98
Closed -$1K 5034
2022
Q3
$1K Sell
98
-56
-36% -$571 ﹤0.01% 4853
2022
Q2
$1K Sell
154
-228
-60% -$1.48K ﹤0.01% 5274
2022
Q1
$7K Sell
382
-1,332
-78% -$24.4K ﹤0.01% 4904
2021
Q4
$45K Buy
1,714
+1,245
+265% +$32.7K ﹤0.01% 4355
2021
Q3
$17K Buy
469
+33
+8% +$1.2K ﹤0.01% 4546
2021
Q2
$24K Buy
436
+65
+18% +$3.58K ﹤0.01% 4526
2021
Q1
$31K Sell
371
-260
-41% -$21.7K ﹤0.01% 4328
2020
Q4
$72K Buy
631
+243
+63% +$27.7K ﹤0.01% 3892
2020
Q3
$12K Sell
388
-65
-14% -$2.01K ﹤0.01% 4220
2020
Q2
$20K Sell
453
-71
-14% -$3.14K ﹤0.01% 4258
2020
Q1
$19K Sell
524
-51
-9% -$1.85K ﹤0.01% 4395
2019
Q4
$38K Sell
575
-950
-62% -$62.8K ﹤0.01% 4152
2019
Q3
$237K Buy
1,525
+2
+0.1% +$311 ﹤0.01% 2999
2019
Q2
$131K Buy
1,523
+26
+2% +$2.24K ﹤0.01% 3454
2019
Q1
$207K Sell
1,497
-3,240
-68% -$448K ﹤0.01% 3108
2018
Q4
$1.9M Buy
4,737
+4,500
+1,899% +$1.81M ﹤0.01% 1574
2018
Q3
$168K Buy
237
+123
+108% +$87.2K ﹤0.01% 3267
2018
Q2
$61K Sell
114
-2
-2% -$1.07K ﹤0.01% 3741
2018
Q1
$13K Buy
+116
New +$13K ﹤0.01% 4388